"Established in 1993 CMAX is one of Australia’s largest and most experienced clinical trial centres. Our expert team is committed to supporting innovative medical research in partnership with our national and international sponsors"

During the past decade, CMAX conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 8 clinical trials were completed, i.e. on average, 9.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 8 clinical trials were completed. i.e. 14% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CMAX" #1 sponsor was "Concert Pharmaceuticals" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Seqirus" with 4 trials sponsored, "Novavax" with 3 trials sponsored and "Qpex Biopharma, Inc." with 3 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CMAX" #1 collaborator was "CPR Pharma Services Pty Ltd, Australia" with 4 trials as a collaborator, "Novotech (Australia) Pty Limited" with 4 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Avance Clinical Pty Ltd." with 2 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "CMAX" are "Healthy" (20 trials), "Healthy Volunteers" (13 trials), "Influenza" (8 trials), "Bacterial Infections" (7 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "CMAX" in a lesser frequency.

Most popular intervention types in "CMAX" are "Drug" (87 trials), "Biological" (19 trials), "Other" (10 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "RPX7009" (3 trials), "AVP-923" (2 trials), "CTP-730" (2 trials) and "Eurartesim" (2 trials). Other intervention names were less common.

The vast majority of trials in "CMAX" are 97 trials for "All" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "CMAX". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in CMAX, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CMAX, 84 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".